Alexion to start Soliris in COVID-19 Phase II trial in next few days

Alexion to start Soliris in COVID-19 Phase II trial in next few days: Alexion Pharmaceuticals is revving up to enter the COVID-19 drug development race with Soliris (eculizumab), a drug that is already approved for other indications, a source familiar with the trial told Reynald Castañeda

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

Prizm Payment Services changes its name to Hitachi Payment Services

Japan's Sharp to buy Toshiba PC business for $36 mln